3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase 3b trial

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          The Lancet Gastroenterology & Hepatology
          The Lancet Gastroenterology & Hepatology
          Elsevier BV
          24681253
          January 2019
          January 2019
          : 4
          : 1
          : 45-51
          Article
          10.1016/S2468-1253(18)30341-8
          30393106
          bc05014f-9f24-4bef-b304-e649c2413109
          © 2019

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article